LA-CB1 demonstrated potent anti-proliferative effects in various breast cancer cell lines, with notable efficacy in triple-negative breast cancer (TNBC) and HR + breast cancer models. This evidence concerns the gene CNR1 and triple-negative breast carcinoma.